IPOs and Secondaries
IPOs and Secondaries Articles
BATS Global Markets has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Atkore International Group has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering.
Published:
Last Updated:
A new report from the State Comptroller's Office of New York showed that both bonuses and profits on Wall Street declined in 2015.
Published:
Last Updated:
Wingstop plans to offer 5 million shares in a secondary offering that is valued up to more than $150 million.
Published:
Last Updated:
The first week of March continued the initial public offering (IPO) drought that started in December and dwindled to just one offering in February. One biotech firm, Syndax Pharmaceuticals Inc....
Published:
Last Updated:
UDR is moving into the big leagues with its announcement that it will be joining the Standard & Poor’s (S&P) 500 Index.
Published:
Last Updated:
A fresh research report from Credit Suisse effectively signals that Marathon shares could still double.
Published:
Last Updated:
Azure Power Global has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
QEP Resources saw its shares move down handily on Monday following the pricing of its secondary offering.
Published:
Last Updated:
American Renal Associates Holdings has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
The market for initial public offerings (IPOs) in February was the slowest since 2009. The sole IPO to make it out the door last week was a blank-check company that intends to focus on buying assets...
Published:
Last Updated:
Syndax Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Wingstop plans to offer 5 million shares in a secondary offering valued up to more than $132 million, at the most recent closing price.
Published:
Last Updated:
Acacia Communications has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Syndax Pharmaceuticals expects to price more than 4 million shares in the range of $14 to $16 for an initial public offering valued up to almost $81 million.
Published:
Last Updated: